Seeking Alpha

Aegerion Pharmaceuticals (AEGR +8.8%) trades up in reaction to a positive FDA staff report on...

Aegerion Pharmaceuticals (AEGR +8.8%) trades up in reaction to a positive FDA staff report on its drug lomitapide. The drug treats a rare genetic disorder that causes very high cholesterol, and the report said that AEGR's plan to manage risk associated with it supports approval in adults with the most life-threatening forms. The drug is due to be reviewed on Wednesday by a committee of non-FDA medical experts, and the FDA will make a final decision by the end of December.
From other sites
Comments (1)
  • FocalPoint Analytics
    , contributor
    Comments (6062) | Send Message
     
    That's one way to reduce cholesterol... reduce the functionality of the liver, the organ most responsible for making cholesterol.
    15 Oct 2012, 11:34 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs